Drug Shortage Report for BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP

Last updated on 2024-03-22 History
Report ID 181448
Drug Identification Number 00037818
Brand name BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
Common or Proper name BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 9MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 25 x 20mL vial
ATC code B05CB
ATC description IRRIGATING SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-03
Estimated end date
Actual end date 2024-03-21
Shortage status Resolved
Updated date 2024-03-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-03-22 English Compare
v16 2024-03-21 French Compare
v15 2024-03-21 English Compare
v14 2024-03-21 French Compare
v13 2024-03-21 English Compare
v12 2023-08-01 French Compare
v11 2023-08-01 English Compare
v10 2023-05-30 French Compare
v9 2023-05-30 English Compare
v8 2023-04-19 French Compare
v7 2023-04-19 English Compare
v6 2023-03-04 English Compare
v5 2023-03-03 French Compare
v4 2023-03-03 English Compare
v3 2023-03-02 English Compare
v2 2023-01-18 French Compare
v1 2023-01-18 English Compare

Showing 1 to 17 of 17